Presented at the 4th International Symposium on Innovative Approaches in Engineering and Natural Sciences (ISAS WINTER-2019 (ENS)), Samsun, Turkey, Nov 22, 2019

SETSCI Conference Proceedings, 2019, 9, Page (s): 512-515 , https://doi.org/10.36287/setsci.4.6.146

Published Date: 22 December 2019    | 533     3

Anti-thyroid drugs are relatively simple molecules known as thionamides, which contain a sulfhydryl group and a thiourea moiety within a heterocyclic structure [1]. Methimazole (1-methyl-2-mercaptoimidazole) is widely used drug in medicine for treatment of hyperthyroidism [2]. The HPLC methods are adequate methods to quantify a drug in pure form and its dosage form. Since HPLC is simple, specific, rapid, precise and accurate, this mehod may be successfully and conveniently adopted for routine quality control analysis of drugs in bulk and pharmaceutical dosage form. Analysis of basic drugs by HPLC can represent problems due to ineractions with stationary phase. YMC-Triart C18 has an extremely low level of metal impurities, much lower than conventional products. YMC-Triart C18's innovative surface modification technology results in excellent peak shapes even for the basic compounds that often exhibit tailing shapes on conventional silica and hybrid silica based ODS columns. In the present study, a simple, rapid and reproducible  reversed phase liquid chromatographic (RPLC) method was developed for the quantification of thiamazole (methimazole) in pharmaceutical dosage form. The chromatographic separation was performed using a YMC Triart C18 (150 mm X 4,6 mm, 3μm) column under the following chromatographic conditions: column temperature: 25°C, the flow rate: 0.8 mL/min. The detection wavelength of thiamazole was 240 nm and metronidazole was chosen as an internal standard. The calibration graph shows that linear response was obtained over the range of concentrations used in the assay procedure. The proposed RPLC method was successfully applied to the determination of thiamazole in commercial tablet formulation.

Keywords - Methimazole, validation, tablet formulation, RPLC, recovery

Kime, D. E., 1998. Springer Science+Business Media New York, Pages 1-13.
[2] Brenner,‎ G.M., Stevens, C., 2018. Brenner and Stevens’ Pharmacology. Elsevier; 5th edition.
[3] Cooper, D.S., 2005. Antithyroid Drugs. The New England Journal of Medicine, 352(9), 905-917.
[4] Fröhlich, E., Wahl, R., 2017. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroi and extra-Thyroidal Diseases. Frontiers in Immunology, 8, 521.
[5] Bouma, D.J., Kammer, H., Greer, M.A., 1982. Follow-Up Comparison of Short-Term Versus 1-Year Antithyroid Drug Therapy for the Thyrotoxicosis of Graves' Disease. The Journal of Clinical Endocrinology & Metabolism, 55(6), 1138–1142.
[6] Romaldini, J.H., Bromberg, N., Werner, R.S., Tanaka, L.M., Rodrigues, H.F., Werner, M.C., Farah, C.S., Reis, L.C.F., 1983. Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves' Hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 57(3), 563-570.
[7] Laurberg, P., Torring, J., Weeke,J., 1985. A comparison of the effects of propylthiouracil and methimazol on circulating thyroid hormones and various measures of peripheral thyroid hormone effects in thyrotoxic patients. Acta Endocrinologica, 108, 51-54.
[8] Laurberg, P., Buchholtz Hansen, P.E., Iversen, E., Jensen, S.E., Weeke, J., 1986. Goitre size and outcome of medical treatment of Graves' disease. Acta Endocrinologica, 111(1), 39-43. [9] Coooper, D.S., 1986. Which Anti-Thyroid Drug? The American Journal of Medicine, 80 (6), 1165–1168.
[10] Velkeniers, B., Vanhaelst, Cytryn, L.R., Jonckheer, M.H., 1988. Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. The Lancet, 331 (8595), 1127-1129.
[11] Biswas, N., Thomas, S., Sarkar, A., Mukherjee, T., Sudhir Kapoor, S., 2009. Adsorption of Methimazole on Silver Nanoparticles: FTIR, Raman, and Surface-Enhanced Raman Scattering Study Aided by Density Functional Theory. Journal of Physical Chemistry C, 113, 7091–7100
[12] Chemicalize, 2019. https://chemicalize.com/#/calculation. Accessed November, 2019.
[13] Hollosi, L., 2005. Development and Application of Analytical Methods for the Determination of Methimazole and its Metabolites and Their Effects to Thyroid Homeostasis in Zebrafish (D. rerio). Technische Universität München, PhD dissertation.
[14] ymc.co.jp/data/download/Triart_catalog_eng.pdf. Accessed:12.11.2019.
[15] https://www.waters.com/webassets/cms/library/docs/wa20756.pdf. Accessed:28.11.2019.
[16] ICH, 2005. Validation of Analytical Procedures: Text and Methodology Q2(R1). Access: 22.11.2018. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.
[17] Rondinini, S., Mussini, P.R, Mussini, T. (1987). Reference value standards and primary standards for ph measurements in organic solvents and water+organic solvent mixtures of moderate to high permittivities. Pure and Applied Chemistry, 59, 1549-1560.
[18] Purnell, J.H., 1960. The correlation of separating power and eficiency of gas-chromatographic columns. Journal of the Chemical Society, 0, 1268-1274.
[19] FDA, 1995. Q2A Text on Validation of Analytical Procedures. Access: 30.04.2019. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2-r1-validation-analytical-procedures-text-and-methodology.
[20] Agilent, 2015. Access: 30.04.2019. https://www.agilent.com/cs/library/eseminars/public/Validated%20HPLC%20Methods.pdf.
[21] Gündüz, T., 2010. Kimyacılar İçin İstatistik. Gazi Kitabevi, 292s, Ankara.